Initial evidence of the beneficial effects of glutamate-modulating agents in the treatment of self-injurious behavior associated with borderline personality disorder [3]

Journal of Clinical Psychiatry

Volumn 66, Issue 11, 2005, Pages 1492-1493

  Pittenger, Christopher ^a   Krystal, John H ^a   Coric, Vladimir ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPRAZOLAM; AMFEBUTAMONE; ARIPIPRAZOLE; CITALOPRAM; CLONAZEPAM; FLUOXETINE; GABAPENTIN; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; LAMOTRIGINE; LORAZEPAM; MIRTAZAPINE; OLANZAPINE; RILUZOLE; RISPERIDONE; SERTRALINE; TOPIRAMATE; TRAZODONE; VENLAFAXINE;

ADULT; AUTOMUTILATION; BEHAVIOR THERAPY; BORDERLINE STATE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COGNITIVE THERAPY; DRUG EFFICACY; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; LETTER; MAJOR DEPRESSION; OBSESSIVE COMPULSIVE DISORDER; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOTHERAPY; TREATMENT OUTCOME;

EID: 28844505064     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v66n1121d     Document Type: Letter

References (20)

1. Lieb K, Zanarini MC, Schmahl C, et al. Borderline personality disorder. Lancet 2004;364:453-461
2. Roth AS, Ostroff RB, Hoffman RE. Naltrexone as a treatment for repetitive self-injurious behavior: an open label trial. J Clin Psychiatry 1996;57:233-237
3. Philipsen A, Richter H, Schmahl C, et al. Clonidine in acute aversive inner tension and self-injurious behavior in female patients with borderline personality disorder. J Clin Psychiatry 2004;65:1414-1419
4. Urbani A, Belluzzi O. Riluzole inhibits the persistent sodium current in mammalian CNS neurons. Eur J Neurosci 2000;12:3567-3574
5. Jehle T, Bauer J, Blauth E, et al. Effects of riluzole on electrically evoked neurotransmitter release. Br J Pharmacol 2000;130:1227-1234
6. Berman RM, Cappiello A, Anand A, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000;47:351-354
7. Rosenberg DR, MacMaster FP, Keshavan MS, et al. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 2000;39:1096-1103
8. Coric V, Milanovic S, Wasylink S, et al. Beneficial effects of the anti-glutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder [letter]. Psychopharmacology (Berl) 2003;167:219-220
9. Zarate CA, Payne JL, Quiroz J, et al. An open-label trial of riluzole in patients with treatment-resistant major depression. Am J Psychiatry 2004;161:171-174
10. Sanacora G, Kendell SF, Fenton L, et al. Riluzole augmentation for treatment-resistant depression [letter]. Am J Psychiatry 2004;161:2132
11. Zarate CA Jr, Quiroz JA, Singh JB, et al. An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biol Psychiatry 2005;57:430-432
12. Coric V, Taskiran S, Pittenger C, et al. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biol Psychiatry 2005;58:424-428
13. Baker DA, McFarland K, Lake RW, et al. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci 2003;6:743-749
14. King BH, Cromwell HC, Lee HT, et al. Dopaminergic and glutamatergic interactions in the expression of self-injurious behavior. Dev Neurosci 1998;20:180-187
15. Shishido T, Watanabe Y, Kato K, et al. Effects of dopamine, NMDA, opiate, and serotonin-related agents on acute methamphetamine-induced self-injurious behavior in mice. Pharmacol Biochem Behav 2000;66:579-583
16. Uvebrant P, Bauziene R. Intractable epilepsy in children: the efficacy of lamotrigine treatment, including non-seizure-related benefits. Neuropediatrics 1994;25:284-289
17. Davanzo PA, King BH. Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation. J Child Adolesc Psychopharmacol 1996;6:273-279
18. Shapira NA, Lessig MC, Murphy TK, et al. Topiramate attenuates the self-injurious behavior in Prader-Willi syndrome. Int J Neuropsychopharmacol 2002;5:141-145
19. Preston GA, Marchant BK, Reimherr FW, et al. Borderline personality isorder in patients with bipolar disorder and response to lamotrigine. J Affect Disord 2004;79:297-303
20. Rilutek (riluzole). Physician's Desk Reference. Montvale, NJ: Thompson Healthcare; 2004